CLABSI prevention bundle for adult haematological patients

0

Hematologic malignancy (hemeonc) and bone marrow transplant (BMT) patients are at higher risk of central line associated bloodstream infection (CLABSI) due to their dependency on central lines for treatment” Dombecki et al (2017).

Background:

Hematologic malignancy (hemeonc) and bone marrow transplant (BMT) patients are at higher risk of central line associated bloodstream infection (CLABSI) due to their dependency on central lines for treatment. Special considerations need to be taken into account when developing effective strategies to prevent CLABSI in this patient population.

Reference:

Dombecki, C., Vercher, J., Valyko, A., Mills, J. and Washer, L. (2017) Implementation of a Central Line-associated Bloodstream Infection (CLABSI) Prevention Bundle for Adult Hematologic Malignancy and Bone Marrow Transplant Patients. American Journal of Infection Control. 45(6), Supplement, p.S103.

DOI: http://dx.doi.org/10.1016/j.ajic.2017.04.166

Thank you to our partners for supporting IVTEAM

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.